Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis - furosemide - solution for injection - 10 mg/ml

Združene države Amerike - angleščina - NLM (National Library of Medicine)

validus pharmaceuticals llc - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - furosemide 20 mg - lasix is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome.  lasix is particularly useful when an agent with greater diuretic potential is desired. oral lasix may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents.  hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with lasix alone. lasix is contraindicated in patients with anuria and in patients with a history of hypersensitivity to furosemide.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

remedyrepack inc. - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - lasix is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome.  lasix is particularly useful when an agent with greater diuretic potential is desired. oral lasix may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents.  hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with lasix alone. lasix is contraindicated in patients with anuria and in patients with a history of hypersensitivity to furosemide.

Singapur - angleščina - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - furosemide - injection - 20 mg/2 ml

Bahrajn - angleščina - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

yousif mahmood hussain pharmacy - furosemide - injection - 20

Kanada - angleščina - Health Canada

sanofi-aventis canada inc - furosemide - solution - 10mg - furosemide 10mg - loop diuretics

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - furosemide - solution for injection - 10mg/1ml

Japonska - angleščina - すりの適正使用協議会 RAD-AR Council, Japan

nichi-iko pharmaceutical co.,ltd - furosemide - injection

Japonska - angleščina - すりの適正使用協議会 RAD-AR Council, Japan

nichi-iko pharmaceutical co.,ltd - furosemide - injection

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cefalotin sodium, quantity: 1.058 g (equivalent: cefalotin, qty 1 g) - injection, powder for - excipient ingredients: sodium bicarbonate - indications: cephalothin sodium for injection is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. culture and susceptibility studies should be performed. however, therapy may be instituted before results of susceptibility studies are obtained (see pharmacology: microbiology). respiratory tract: infections caused by s. pneumoniae, staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, klebsiella, and h. influenzae. skin and soft tissue: infections, including peritonitis, caused by staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, e.coli, pr. mirabilis and klebsiella. genitourinary tract: infections caused by e. coli, pr. mirabilis and klebsiella. septicaemia, including endocarditis: infections caused by s. pneumoniae, staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, s. viridans, e. coli, pr. mirabilis and klebsiella. bone and joint: infection caused by staphylococci (penicillinase and non-penicillinase producing). prophylactically in vaginal hysterectomy, head and neck surgery, insertion of prosthetic heart valves, and prosthetic arthroplasty. cephalothin is not recommended for gastrointestinal procedures or other sites where anaerobic organisms such as bacteriodes tend to prevail. dosage is required pre-, intra-and postoperatively (i.e perioperatively, see dosage and administration). if signs of postoperative infection develop, specimens should be cultured to identify the causative organism so that appropriate therapy can be instituted. note: if the susceptibility tests show that the causative organism is resistant to cephalothin, other appropriate antibiotic therapy should be instituted.